Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
Clinical trial NCT04209686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04209686
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2028-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.